COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

Up to 20%–30% of patients hospitalized with coronavirus disease 2019 (COVID-19) have evidence of myocardial involvement. Acute cardiac injury in patients hospitalized with COVID-19 is associated with higher morbidity and mortality. There are no data on how acute treatment of COVID-19 may affect the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Heart rhythm 2020-11, Vol.17 (11), p.1984-1990
Hauptverfasser: Mitrani, Raul D., Dabas, Nitika, Goldberger, Jeffrey J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1990
container_issue 11
container_start_page 1984
container_title Heart rhythm
container_volume 17
creator Mitrani, Raul D.
Dabas, Nitika
Goldberger, Jeffrey J.
description Up to 20%–30% of patients hospitalized with coronavirus disease 2019 (COVID-19) have evidence of myocardial involvement. Acute cardiac injury in patients hospitalized with COVID-19 is associated with higher morbidity and mortality. There are no data on how acute treatment of COVID-19 may affect the convalescent phase or long-term cardiac recovery and function. Myocarditis from other viral pathogens can evolve into overt or subclinical myocardial dysfunction, and sudden death has been described in the convalescent phase of viral myocarditis. This raises concerns for patients recovering from COVID-19. Some patients will have subclinical and possibly overt cardiovascular abnormalities. Patients with ostensibly recovered cardiac function may still be at risk of cardiomyopathy and cardiac arrhythmias. Screening for residual cardiac involvement in the convalescent phase for patients recovered from COVID-19–associated cardiac injury is needed. The type of testing and therapies for post COVID-19 myocardial dysfunction will need to be determined. Therefore, now is the time to plan for appropriate registries and clinical trials to properly assess these issues and prepare for long-term sequelae of “post–COVID-19 cardiac syndrome.”
doi_str_mv 10.1016/j.hrthm.2020.06.026
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7319645</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1547527120306251</els_id><sourcerecordid>2419095295</sourcerecordid><originalsourceid>FETCH-LOGICAL-c459t-223630a754a7887e5679088f90321098c6a25ea583f49e3d5543217eead2b61d3</originalsourceid><addsrcrecordid>eNp9kctKxDAUhoMoXkafQJAu3bTm0iSNoCDjbUBwoy7chJieOhnaZkzaAd_e1lHRjasE_stJzofQIcEZwUScLLJ56OZNRjHFGRYZpmID7RLORcoKSTbHey5TTiXZQXsxLjCmSmC2jXYY5UoRWeyi5-n90-wyJSqxJpTO2MS1iz68nyazZlk7azrn25hUPiS1b1_TDkKTxD6swNW1aS0kpi0T33fWNxCH8KfoVj7EfbRVmTrCwdc5QY_XVw_T2_Tu_mY2vbhLbc5Vl1LKBMNG8tzIopDAhVS4KCqFGSVYFVYYysHwglW5AlZyng-CBDAlfRGkZBN0vu5d9i8NlBbaLphaL4NrTHjX3jj9V2ndXL_6lZaMKJHzoeD4qyD4tx5ipxsXLYz_A99HTXOisOJUjVa2ttrgYwxQ_YwhWI9U9EJ_UtEjFY2FHqgMqaPfL_zJfGMYDGdrAwx7WjkIOloHw3ZLF8B2uvTu3wEfgOefng</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419095295</pqid></control><display><type>article</type><title>COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Mitrani, Raul D. ; Dabas, Nitika ; Goldberger, Jeffrey J.</creator><creatorcontrib>Mitrani, Raul D. ; Dabas, Nitika ; Goldberger, Jeffrey J.</creatorcontrib><description>Up to 20%–30% of patients hospitalized with coronavirus disease 2019 (COVID-19) have evidence of myocardial involvement. Acute cardiac injury in patients hospitalized with COVID-19 is associated with higher morbidity and mortality. There are no data on how acute treatment of COVID-19 may affect the convalescent phase or long-term cardiac recovery and function. Myocarditis from other viral pathogens can evolve into overt or subclinical myocardial dysfunction, and sudden death has been described in the convalescent phase of viral myocarditis. This raises concerns for patients recovering from COVID-19. Some patients will have subclinical and possibly overt cardiovascular abnormalities. Patients with ostensibly recovered cardiac function may still be at risk of cardiomyopathy and cardiac arrhythmias. Screening for residual cardiac involvement in the convalescent phase for patients recovered from COVID-19–associated cardiac injury is needed. The type of testing and therapies for post COVID-19 myocardial dysfunction will need to be determined. Therefore, now is the time to plan for appropriate registries and clinical trials to properly assess these issues and prepare for long-term sequelae of “post–COVID-19 cardiac syndrome.”</description><identifier>ISSN: 1547-5271</identifier><identifier>EISSN: 1556-3871</identifier><identifier>DOI: 10.1016/j.hrthm.2020.06.026</identifier><identifier>PMID: 32599178</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Arrhythmia ; Arrhythmias, Cardiac - diagnosis ; Arrhythmias, Cardiac - etiology ; Arrhythmias, Cardiac - virology ; Betacoronavirus - pathogenicity ; Cardiac injury ; Cardiomyopathy ; Cardiovascular Diseases - diagnosis ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - virology ; Contemporary Review ; Convalescence ; Coronavirus Infections - complications ; Coronavirus Infections - physiopathology ; COVID-19 ; Diagnostic Screening Programs ; Health Services Needs and Demand ; Humans ; Myocarditis ; Pandemics ; Pneumonia, Viral - complications ; Pneumonia, Viral - physiopathology ; SARS-CoV-2 ; Survival Analysis ; Survivors</subject><ispartof>Heart rhythm, 2020-11, Vol.17 (11), p.1984-1990</ispartof><rights>2020 Heart Rhythm Society</rights><rights>Copyright © 2020 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 Heart Rhythm Society. All rights reserved. 2020 Heart Rhythm Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c459t-223630a754a7887e5679088f90321098c6a25ea583f49e3d5543217eead2b61d3</citedby><cites>FETCH-LOGICAL-c459t-223630a754a7887e5679088f90321098c6a25ea583f49e3d5543217eead2b61d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.hrthm.2020.06.026$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32599178$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mitrani, Raul D.</creatorcontrib><creatorcontrib>Dabas, Nitika</creatorcontrib><creatorcontrib>Goldberger, Jeffrey J.</creatorcontrib><title>COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors</title><title>Heart rhythm</title><addtitle>Heart Rhythm</addtitle><description>Up to 20%–30% of patients hospitalized with coronavirus disease 2019 (COVID-19) have evidence of myocardial involvement. Acute cardiac injury in patients hospitalized with COVID-19 is associated with higher morbidity and mortality. There are no data on how acute treatment of COVID-19 may affect the convalescent phase or long-term cardiac recovery and function. Myocarditis from other viral pathogens can evolve into overt or subclinical myocardial dysfunction, and sudden death has been described in the convalescent phase of viral myocarditis. This raises concerns for patients recovering from COVID-19. Some patients will have subclinical and possibly overt cardiovascular abnormalities. Patients with ostensibly recovered cardiac function may still be at risk of cardiomyopathy and cardiac arrhythmias. Screening for residual cardiac involvement in the convalescent phase for patients recovered from COVID-19–associated cardiac injury is needed. The type of testing and therapies for post COVID-19 myocardial dysfunction will need to be determined. Therefore, now is the time to plan for appropriate registries and clinical trials to properly assess these issues and prepare for long-term sequelae of “post–COVID-19 cardiac syndrome.”</description><subject>Arrhythmia</subject><subject>Arrhythmias, Cardiac - diagnosis</subject><subject>Arrhythmias, Cardiac - etiology</subject><subject>Arrhythmias, Cardiac - virology</subject><subject>Betacoronavirus - pathogenicity</subject><subject>Cardiac injury</subject><subject>Cardiomyopathy</subject><subject>Cardiovascular Diseases - diagnosis</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - virology</subject><subject>Contemporary Review</subject><subject>Convalescence</subject><subject>Coronavirus Infections - complications</subject><subject>Coronavirus Infections - physiopathology</subject><subject>COVID-19</subject><subject>Diagnostic Screening Programs</subject><subject>Health Services Needs and Demand</subject><subject>Humans</subject><subject>Myocarditis</subject><subject>Pandemics</subject><subject>Pneumonia, Viral - complications</subject><subject>Pneumonia, Viral - physiopathology</subject><subject>SARS-CoV-2</subject><subject>Survival Analysis</subject><subject>Survivors</subject><issn>1547-5271</issn><issn>1556-3871</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctKxDAUhoMoXkafQJAu3bTm0iSNoCDjbUBwoy7chJieOhnaZkzaAd_e1lHRjasE_stJzofQIcEZwUScLLJ56OZNRjHFGRYZpmID7RLORcoKSTbHey5TTiXZQXsxLjCmSmC2jXYY5UoRWeyi5-n90-wyJSqxJpTO2MS1iz68nyazZlk7azrn25hUPiS1b1_TDkKTxD6swNW1aS0kpi0T33fWNxCH8KfoVj7EfbRVmTrCwdc5QY_XVw_T2_Tu_mY2vbhLbc5Vl1LKBMNG8tzIopDAhVS4KCqFGSVYFVYYysHwglW5AlZyng-CBDAlfRGkZBN0vu5d9i8NlBbaLphaL4NrTHjX3jj9V2ndXL_6lZaMKJHzoeD4qyD4tx5ipxsXLYz_A99HTXOisOJUjVa2ttrgYwxQ_YwhWI9U9EJ_UtEjFY2FHqgMqaPfL_zJfGMYDGdrAwx7WjkIOloHw3ZLF8B2uvTu3wEfgOefng</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Mitrani, Raul D.</creator><creator>Dabas, Nitika</creator><creator>Goldberger, Jeffrey J.</creator><general>Elsevier Inc</general><general>Heart Rhythm Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20201101</creationdate><title>COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors</title><author>Mitrani, Raul D. ; Dabas, Nitika ; Goldberger, Jeffrey J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c459t-223630a754a7887e5679088f90321098c6a25ea583f49e3d5543217eead2b61d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Arrhythmia</topic><topic>Arrhythmias, Cardiac - diagnosis</topic><topic>Arrhythmias, Cardiac - etiology</topic><topic>Arrhythmias, Cardiac - virology</topic><topic>Betacoronavirus - pathogenicity</topic><topic>Cardiac injury</topic><topic>Cardiomyopathy</topic><topic>Cardiovascular Diseases - diagnosis</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - virology</topic><topic>Contemporary Review</topic><topic>Convalescence</topic><topic>Coronavirus Infections - complications</topic><topic>Coronavirus Infections - physiopathology</topic><topic>COVID-19</topic><topic>Diagnostic Screening Programs</topic><topic>Health Services Needs and Demand</topic><topic>Humans</topic><topic>Myocarditis</topic><topic>Pandemics</topic><topic>Pneumonia, Viral - complications</topic><topic>Pneumonia, Viral - physiopathology</topic><topic>SARS-CoV-2</topic><topic>Survival Analysis</topic><topic>Survivors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mitrani, Raul D.</creatorcontrib><creatorcontrib>Dabas, Nitika</creatorcontrib><creatorcontrib>Goldberger, Jeffrey J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heart rhythm</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mitrani, Raul D.</au><au>Dabas, Nitika</au><au>Goldberger, Jeffrey J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors</atitle><jtitle>Heart rhythm</jtitle><addtitle>Heart Rhythm</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>17</volume><issue>11</issue><spage>1984</spage><epage>1990</epage><pages>1984-1990</pages><issn>1547-5271</issn><eissn>1556-3871</eissn><abstract>Up to 20%–30% of patients hospitalized with coronavirus disease 2019 (COVID-19) have evidence of myocardial involvement. Acute cardiac injury in patients hospitalized with COVID-19 is associated with higher morbidity and mortality. There are no data on how acute treatment of COVID-19 may affect the convalescent phase or long-term cardiac recovery and function. Myocarditis from other viral pathogens can evolve into overt or subclinical myocardial dysfunction, and sudden death has been described in the convalescent phase of viral myocarditis. This raises concerns for patients recovering from COVID-19. Some patients will have subclinical and possibly overt cardiovascular abnormalities. Patients with ostensibly recovered cardiac function may still be at risk of cardiomyopathy and cardiac arrhythmias. Screening for residual cardiac involvement in the convalescent phase for patients recovered from COVID-19–associated cardiac injury is needed. The type of testing and therapies for post COVID-19 myocardial dysfunction will need to be determined. Therefore, now is the time to plan for appropriate registries and clinical trials to properly assess these issues and prepare for long-term sequelae of “post–COVID-19 cardiac syndrome.”</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32599178</pmid><doi>10.1016/j.hrthm.2020.06.026</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1547-5271
ispartof Heart rhythm, 2020-11, Vol.17 (11), p.1984-1990
issn 1547-5271
1556-3871
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7319645
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Arrhythmia
Arrhythmias, Cardiac - diagnosis
Arrhythmias, Cardiac - etiology
Arrhythmias, Cardiac - virology
Betacoronavirus - pathogenicity
Cardiac injury
Cardiomyopathy
Cardiovascular Diseases - diagnosis
Cardiovascular Diseases - etiology
Cardiovascular Diseases - virology
Contemporary Review
Convalescence
Coronavirus Infections - complications
Coronavirus Infections - physiopathology
COVID-19
Diagnostic Screening Programs
Health Services Needs and Demand
Humans
Myocarditis
Pandemics
Pneumonia, Viral - complications
Pneumonia, Viral - physiopathology
SARS-CoV-2
Survival Analysis
Survivors
title COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T10%3A38%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=COVID-19%20cardiac%20injury:%20Implications%20for%20long-term%20surveillance%20and%20outcomes%20in%20survivors&rft.jtitle=Heart%20rhythm&rft.au=Mitrani,%20Raul%20D.&rft.date=2020-11-01&rft.volume=17&rft.issue=11&rft.spage=1984&rft.epage=1990&rft.pages=1984-1990&rft.issn=1547-5271&rft.eissn=1556-3871&rft_id=info:doi/10.1016/j.hrthm.2020.06.026&rft_dat=%3Cproquest_pubme%3E2419095295%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419095295&rft_id=info:pmid/32599178&rft_els_id=S1547527120306251&rfr_iscdi=true